Navigation Links
Eye Scan Could Help Track Progress of Multiple Sclerosis
Date:12/25/2012

MONDAY, Dec. 24 (HealthDay News) -- In-office eye scans that assess the thinning of the retina may also help doctors determine how fast multiple sclerosis (MS) is progressing in patients with the nervous system disease, a new study suggests.

The study included 164 MS patients who underwent eye scans every six months for an average of 21 months. The participants also had MRI brain scans at the start of the study and yearly.

Patients with MS relapses had 42 percent faster retinal thinning than those with no relapses, the study found. Patients with inflammatory lesions called gadolinium-enhancing lesions had 54 percent faster retinal thinning, and those with new T2 lesions had 36 percent faster thinning, compared to patients who did not have evidence of such lesions on their MRI brain scans, the investigators found.

In addition, patients whose disability levels worsened during the study period had 37 percent more retinal thinning than those who had no changes in their disability levels.

And compared with patients who had the disease for more than five years, those who had MS for less than five years had 43 percent faster retinal thinning, the study authors noted.

The findings suggest that retinal thinning may occur faster in patients with earlier and more active MS.

The new report appears in the Jan. 1 online edition of the journal Neurology. It updates earlier results from this study, published in the Archives of Neurology in October.

"As more therapies are developed to slow the progression of MS, testing retinal thinning in the eyes may be helpful in evaluating how effective those therapies are," study author Dr. Peter Calabresi, of the Johns Hopkins University School of Medicine, said in a journal news release.

Other experts not connected to the study agreed.

"This study reports an important link between the inflammatory and neurodegenerative aspects of MS that should lead to a better understanding of the underlying mechanisms of tissue damage," said Dr. Fred Lublin, director of the Corinne Goldsmith Dickinson Center for Multiple Sclerosis at the Icahn School of Medicine at Mount Sinai, in New York City. He added that, "The techniques described may add to our ability to better perform studies of neuroprotective agents in MS."

And Dr. Floyd Warren, chief of neuro-ophthalmology at Lenox Hill Hospital, in New York City, called the study "very intriguing."

He stressed, however, that the study was preliminary and "looked primarily at relapsing remitting MS; the progressive forms and clinically isolated syndrome patients were much fewer in number."

Warren agreed with the other experts that these retinal scans might be used to track the effectiveness of new MS drugs, especially since such tests are "totally benign" and have "relatively low cost."

"Further studies with larger numbers of progressive MS patients will need to be done to see if it proves as (potentially) a reliable marker in these patients," he said.

More information

The U.S. National Institute of Neurological Disorders and Stroke has more about multiple sclerosis.

-- Robert Preidt

SOURCES: Floyd Warren, M.D,, chief of neuro-ophthalmology, Lenox Hill Hospital, New York City; Fred Lublin, MD, director, Corinne Goldsmith Dickinson Center for Multiple Sclerosis, Icahn School of Medicine at Mount Sinai, New York City; Neurology, news release, Dec. 24, 2012


'/>"/>
Copyright©2012 ScoutNews,LLC.
All rights reserved  

Related medicine news :

1. New markers could improve treatment and survival in acute lymphoblastic leukaemia
2. Super-fine sound beam could one day be an invisible scalpel
3. InventHelp Client Patents “LessMess” – Invention Could Reduce Messes and Smells Caused by Splashed Urine
4. Study: Curbing car travel could be as effective as cutting calories
5. Mind-Controlled Prosthetic Hand Could Be Breakthrough
6. Student-athletes could lose eligibility, scholarships with tweet missteps, Baylor research shows
7. Study shows antidepressant could do double duty as diabetes drug
8. A finding that could help Alpha-1 sufferers breathe more easily
9. Discovery in Ghent could improve screening for sudden cardiac death
10. Capturing circulating cancer cells could provide insights into how disease spreads
11. Porcupine Quill Could Foster New Medical Devices
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Eye Scan Could Help Track Progress of Multiple Sclerosis 
(Date:2/10/2016)... FL (PRWEB) , ... February 10, 2016 , ... AxoGen, ... market, will report results for the fourth quarter and full year ended December 31, ... host a conference call and webcast for the investment community following the release at ...
(Date:2/10/2016)... ... February 10, 2016 , ... AHRA: The ... and inspirational speaker Jan Fox will serve as keynote speaker at the organization’s ... participants with tools to more effectively communicate with their own organizational staff and ...
(Date:2/10/2016)... ... February 10, 2016 , ... For additional information contact Phyllis Strupp ... book "Better with Age: The Ultimate Guide to Brain Training" by award-winning author ... The book’s publication date is March 16, 2016. A free review copy is ...
(Date:2/10/2016)... Beach, Florida (PRWEB) , ... February 10, 2016 ... ... Country Club) announced that it has been awarded the prestigious Distinguished Emerald Club ... World award program conducted by BoardRoom magazine, one of the most respected trade ...
(Date:2/10/2016)... , ... February 10, 2016 , ... ... biocompatible columns and accessories. These PEEK-lined stainless steel (PLS) columns combine the strength ... solution that ensures the integrity of biological samples while operating at ultra-high pressures ...
Breaking Medicine News(10 mins):
(Date:2/10/2016)... PITTSBURGH , 10 februari 2016 ... detta pressmeddelande får inte distribueras, vare sig ... inga anmälningssedlar kommer att accepteras från eller ... där Erbjudandet, distribution av detta pressmeddelande eller ... mot tillämpliga lagar eller regler eller skulle ...
(Date:2/10/2016)... , February 10, 2016 A new report from ... - states that the Alzheimer,s disease market will more than double from ... at a Compound Annual Growth Rate (CAGR) of 11%. Canada ... Italy , Spain , the UK, and ... during the forecast period. --> Canada , ...
(Date:2/10/2016)... , Feb. 10, 2016 Urologix, the ... the treatment of Benign Prostatic Hyperplasia (BPH), announces new ... Ash Keswani , a medical device industry veteran of ... the Limited Liability Company.  Plymouth, ... service lines, Cooled ThermoTherapy™ and Prostiva® RF Therapy, will ...
Breaking Medicine Technology: